✦ LIBER ✦

PPARγ agonists as a new class of effective treatment for ulcerative colitis

✍ Scribed by Pierre Desreumaux; Laurent Dubuquoy

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 56 KB
Volume: 15
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.20765

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Aleglitazar (I), a

ChemInform Abstract: Aleglitazar (I), a New, Potent, and Balanced Dual PPARα/γ Agonist for the Treatment of Type II Diabetes.

✍ Peter Mohr; et al. et al. 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 13 KB 👁 1 views

Effect of weekend 5-aminosalicylic acid

Effect of weekend 5-aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: Results from a randomized controlled study

✍ Hiroshi Yokoyama; Sho Takagi; Shinichi Kuriyama; Shuichiro Takahashi; Hiroki Tak 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Background: 5-Aminosalicylic acid (5-ASA) is known to be effective in the treatment of active ulcerative colitis (UC). The aim of the current study was to investigate the effect of 5-ASA enemas, as a maintenance therapy for UC, when administered twice weekly as a weekend treatment regimen, compared

Effect of EP4 agonist (ONO-4819CD) for p

Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: A randomized phase II, placebo-controlled trial

✍ Hiroshi Nakase; Yoshihide Fujiyama; Nobuhide Oshitani; Toru Oga; Kimiko Nonomura 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

ChemInform Abstract: Effects of BX661A (

ChemInform Abstract: Effects of BX661A (I), a New Therapeutic Agent for Ulcerative Colitis, on Chemotaxis and Reactive Oxygen Species Production in Polymorphonuclear Leukocytes in Comparison with Salazosulfapyridine and Its Metabolite Sulfapyridine.

✍ Isami Kimura; Maki Kawasaki; Akihiko Matsuda; Mikiko Kataoka; Yukifumi Kokurba 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB 👁 2 views